Health Care & Life Sciences » Pharmaceuticals | Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
12,427.30
5,365.10
2,931.90
5,830.70
25,275.00
29,101
SG&A Expense
11,488.80
12,196.30
15,705.10
28,228.30
39,500.00
59,362
EBIT
553.80
-
13,081.00
22,759.00
14,594.00
30,831
Unusual Expense
-
-
900.00
-
-
-
Non Operating Income/Expense
6.30
3.00
110.90
119.50
2,102.00
1,803
Interest Expense
493.90
2,654.70
-
-
-
-
Pretax Income
66.20
9,850.00
13,854.80
22,637.20
16,544.00
27,066
Income Tax
-
0.00
203.90
162.00
1,103.00
312
Consolidated Net Income
66.20
9,850.00
14,058.60
22,799.20
17,647.00
26,754
Net Income
66.20
9,850.00
14,058.60
22,799.20
17,647.00
26,754
Net Income After Extraordinaries
66.20
9,850.00
14,058.60
22,799.20
17,647.00
26,754
Net Income Available to Common
66.20
9,850.00
14,058.60
22,799.20
17,647.00
26,754
EPS (Basic)
0.00
0.71
0.41
0.55
0.40
0.50
Basic Shares Outstanding
26,884.00
13,872.40
34,392.60
41,713.20
43,931.00
53,081
EPS (Diluted)
0.00
0.71
0.41
0.55
0.40
0.50
Diluted Shares Outstanding
26,884.00
13,872.40
34,392.60
41,713.20
43,931.00
53,081
EBITDA
938.50
6,831.30
12,773.10
22,397.60
14,225.00
30,261
Non-Operating Interest Income
-
-
15.40
2.30
152.00
1,962

About Pieris Pharmaceuticals

View Profile
Address
255 State Street
Boston Massachusetts 02109
United States
Employees -
Website http://www.pieris.com
Updated 07/08/2019
Pieris Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with an unmet medical need. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.